BIO.News Newsletter

Big news today from biopharmaceutical companies about what they’re doing to ensure the public's trust in the safety and efficacy of a future COVID-19 vaccine, plus insights on why we should study bats to help us understand the virus. Here are about 750 words, just under 4 minutes.

Washington’s officially back to work. To kick off the short but sure-to-be-busy week, we take a closer look at Twist Bioscience’s antibody announcement as well as a recent meeting with South Africa’s biotech industry and regulators. Here are around 900 words, 4 and a half minutes.

Before you log off for the holiday weekend, we have the scoop on a new rule that will help ensure patients have access to the latest transformative therapies, as well as a look at how biotech is improving your last summer cookout of the season. Here are 790 words, just under 4 minutes.  Good Day BIO is taking a quick break for Labor Day. We’ll be in touch if there’s major breaking news, but otherwise, we’ll resume regular publication on Tuesday, September 8.

Congrats to BIO members Horizon Therapeutics and AbbVie for being named among PEOPLE Magazine’s 50 Companies That Care, recognizing companies that have gone “above and beyond" for employees during the pandemic. We’re proud to work with you, and so many others, who care about their employees, patients, and the planet. Today, we have news on how the biotech industry is working to build public trust in new medical developments and EPA’s proposed rule that would help modernize plant biotech…

Breaking news! We’re launching a new initiative to help you register to vote and get the information you need to make an informed decision on November 3—no matter which way you lean politically. Details, plus a lot of news links from Washington, in around 670 words, 3 minutes, 20 seconds.

It's September. Today, we hear from experts on the potential of animal biotechnology and the importance of diversity in COVID-19 clinical trials. Here are 900 words, 4 and a half minutes.

It’s the last day of August—and we never thought we’d say this, but we’re so ready for summer to be over. Today, BIO’s Dr. Michelle McMurry-Heath shares her latest insights on the COVID vaccine race, and we look at the role of biotech in our #quarantinekitchens, in around 650 words, 3 minutes, 20 seconds.

It’s the last Friday in what’s been a busy August. Below, what you need to do if you want to network with biotech innovators or investors, plus some news links for the weekend (including an announcement about funding for the EcoHealth Alliance). Here are about 670 words, or 3 minutes, 20 seconds.

COVID-19 is not the only challenge the world is facing—and it’s not the only thing biotech is working on, either. Today, we look at how biotech is tackling other big problems like climate change and antibiotic resistance, and the need for policy to catch up with the science. Here are 825 words, just over 4 minutes.

Surprise! In the middle of an abnormally busy August recess, Senate Democrats released a new climate plan—and it echoes some of BIO’s policy proposals. We have the details, plus a coronavirus vaccine clock update, in around 800 words, 4 minutes.